Michel Fabbro
Papers
1
Total Citations
5
H-Index
1
About
Michel Fabbro is a clinical researcher whose work centers on optimizing treatment protocols in gynecologic oncology, with a particular focus on endometrial carcinoma. His major contribution lies in elucidating the critical role of timing in adjuvant radiation therapy, demonstrating through a multicentric retrospective study that delays in treatment initiation can significantly impact patient outcomes. This landmark 2020 paper, though early in its citation history with five references, has already informed clinical decision-making by highlighting the need for streamlined care pathways. Fabbro’s research bridges the gap between surgical and radiation oncology, providing evidence-based guidelines that help clinicians balance the urgency of postoperative recovery with the imperative for timely oncologic intervention. His work is especially valuable for trainees and practitioners navigating the complexities of multidisciplinary cancer care, as it underscores how logistical factors—not just biological ones—influence prognosis. By quantifying the consequences of treatment delays, Fabbro has laid groundwork for future prospective trials and quality-improvement initiatives in endometrial cancer management, establishing himself as a thoughtful voice in the ongoing effort to refine adjuvant therapy strategies.
Research Focus
Key Achievements
Top Papers
- 1